United Nations & Merck Group

United Nations: Leading the international response coordination, warning of exponential growth and calling for more funding. Its credibility is tied to the effectiveness of the response.

Merck Group: Merck Group's Ervebo vaccine is being deployed in the outbreak response, potentially increasing sales. However, its efficacy against the Bundibugyo strain is unproven, and the trial outcome will be critical.

United Nations: The United Nations is coordinating the response and warning of exponential spread, highlighting the severity of the outbreak. Its role is crucial in mobilizing international support.

Merck Group: Merck Group is the developer of Ervebo, the only approved Ebola vaccine, which is being deployed in the DRC outbreak. Its role is central, and successful cross-protection could expand its market and reputation.

United Nations: Highlighting the shadow crisis of rising maternal deaths as pregnant women avoid hospitals. Its data underscores the indirect health impacts of the outbreak.

Merck Group: Manufacturer of RVSV-ZEBOV vaccine, which is being considered for cross-protection trials. Its vaccine could play a role in the response, benefiting its reputation.